{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["intervertebral disc", "intradiscal therapy", "low back pain", "systematic review"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34349845", "DateRevised": {"Year": "2022", "Month": "04", "Day": "25"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "07", "Day": "16"}], "ELocationID": ["1759720X211028001", "10.1177/1759720X211028001"], "Journal": {"ISSN": "1759-720X", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2021"}}, "Title": "Therapeutic advances in musculoskeletal disease", "ISOAbbreviation": "Ther Adv Musculoskelet Dis"}, "ArticleTitle": "Intervertebral disc therapies for non-specific chronic low back pain: a systematic review and meta-analysis.", "Pagination": {"StartPage": "1759720X211028001", "MedlinePgn": "1759720X211028001"}, "Abstract": {"AbstractText": ["We aim to evaluate the benefits and harms of intervertebral disc therapies (IDTs) in people with non-specific chronic low back pain (NScLBP).", "We conducted a systematic review and meta-analysis of randomized trials of IDTs <i>versus</i> placebo interventions, active comparators or usual care. EMBASE, MEDLINE, CENTRAL and CINHAL databases and conference abstracts were searched from inception to June 2020. Two independent investigators extracted data. The primary outcome was LBP intensity at short term (1\u2009week-3\u2009months), intermediate term (3-6\u2009months) and long term (after 6\u2009months).", "Of 18 eligible trials (among 1396 citations), five assessed glucocorticoids (GCs) IDTs and were included in a quantitative synthesis; 13 assessed other products including etanercept (<i>n</i>\u2009=\u20092), tocilizumab (<i>n</i>\u2009=\u20091), methylene blue (<i>n</i>\u2009=\u20092), ozone (<i>n</i>\u2009=\u20092), chymopapaine (<i>n</i>\u2009=\u20091), glycerol (<i>n</i>\u2009=\u20091), stem cells (<i>n</i>\u2009=\u20091), platelet-rich plasma (<i>n</i>\u2009=\u20091) and recombinant human growth and differentiation factor-5 (<i>n</i>\u2009=\u20092), and were included in a narrative synthesis. Standardized mean differences (95% CI) for GC IDTs for LBP intensity and activity limitations were -1.33 (-2.34; -0.32) and -0.76 (-1.85; 0.34) at short term, -2.22 (-5.34; 0.90) and -1.60 (-3.51; 0.32) at intermediate term and -1.11 (-2.91; 0.70) and -0.63 (-1.68; 0.42) at long term, respectively. Odds ratios (95% CI) for serious and minor adverse events with GC IDTs were 1.09 (0.25; 4.65) and 0.97 (0.49; 1.91).", "GC IDTs are associated with a reduction in LBP intensity at short term in people with NScLBP. Positive effects are not sustained. IDTs have no effect on activity limitations. Our conclusions are limited by high heterogeneity and a limited methodological quality across studies.", "PROSPERO: CRD42019106336."], "CopyrightInformation": "\u00a9 The Author(s), 2021."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e9 de Paris, Facult\u00e9 de Sant\u00e9, UFR de M\u00e9decine de l'Universit\u00e9 de Paris, Paris, France."}], "LastName": "Daste", "ForeName": "Camille", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "AP-HP.Centre-Universit\u00e9 de Paris, Service de R\u00e9\u00e9ducation et de R\u00e9adaptation de l'Appareil Locomoteur et des Pathologies du Rachis, H\u00f4pital Cochin, Paris, France."}], "LastName": "Laclau", "ForeName": "St\u00e9phanie", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "AP-HP.Centre-Universit\u00e9 de Paris, Service de R\u00e9\u00e9ducation et de R\u00e9adaptation de l'Appareil Locomoteur et des Pathologies du Rachis, H\u00f4pital Cochin, Paris, France."}], "LastName": "Boisson", "ForeName": "Margaux", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "AP-HP.Centre-Universit\u00e9 de Paris, Service de R\u00e9\u00e9ducation et de R\u00e9adaptation de l'Appareil Locomoteur et des Pathologies du Rachis, H\u00f4pital Cochin, Paris, France."}], "LastName": "Segretin", "ForeName": "Fran\u00e7ois", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e9 de Paris, Facult\u00e9 de Sant\u00e9, UFR de M\u00e9decine de l'Universit\u00e9 de Paris, Paris, France."}], "LastName": "Feydy", "ForeName": "Antoine", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e9 de Paris, Facult\u00e9 de Sant\u00e9, UFR de M\u00e9decine de l'Universit\u00e9 de Paris, Paris, France."}], "LastName": "Lef\u00e8vre-Colau", "ForeName": "Marie-Martine", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e9 de Paris, Facult\u00e9 de Sant\u00e9, UFR de M\u00e9decine de l'Universit\u00e9 de Paris, Paris, France."}], "LastName": "Rannou", "ForeName": "Fran\u00e7ois", "Initials": "F"}, {"Identifier": ["0000-0001-7141-3230"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "R\u00e9\u00e9ducation et R\u00e9adaptation de l'Appareil Locomoteur et des Pathologies du Rachis, AP-HP.Centre-Universit\u00e9 de Paris, H\u00f4pital Cochin, 27, Rue du Faubourg Saint-Jacques, Paris, 75014, France."}], "LastName": "Nguyen", "ForeName": "Christelle", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Ther Adv Musculoskelet Dis", "NlmUniqueID": "101517322", "ISSNLinking": "1759-720X"}, "CoiStatement": "Conflict of interest statement: AF, MMLC, FR and CN are authors of the following article \u201cNguyen C, Boutron I, Baron G, Sanchez K, Palazzo C, Benchimol R, Paris G, James-Belin \u00c9, Lef\u00e8vre-Colau MM, Beaudreuil J, Laredo JD, B\u00e9ra-Louville A, Cotten A, Drap\u00e9 JL, Feydy A, Ravaud P, Rannou F, Poiraudeau S. Intradiscal Glucocorticoid Injection for Patients With Chronic Low Back Pain Associated With Active Discopathy: A Randomized Trial. Ann Intern Med. 2017 Apr18; 166(8):547\u2013556,\u201d which reported the positive effect of an intradiscal injection of glucocorticoids on pain at short term in patients with chronic low back pain and active discopathy."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "GBD 2017. Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018; 392: 1789\u20131858.", "ArticleIdList": ["PMC6227754", "30496104"]}, {"Citation": "Dionne CE, Dunn KM, Croft PR, et al.. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine 2008; 33: 95\u2013103.", "ArticleIdList": ["18165754"]}, {"Citation": "Haute Autorit\u00e9 de Sant\u00e9. [Lombalgie chronique de l\u2019adulte et chirugie, recommandation de bonne pratique]. 2015."}, {"Citation": "Chou R, Qaseem A, Snow V, et al.. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147: 478\u2013491.", "ArticleIdList": ["17909209"]}, {"Citation": "Smeets RJ, Wade D, Hidding A, et al.. The association of physical deconditioning and chronic low back pain: a hypothesis-oriented systematic review. Disabil Rehabil 2006; 28: 673\u2013693.", "ArticleIdList": ["16809211"]}, {"Citation": "Nguyen C, Lef\u00e8vre-Colau MM, Kennedy DJ, et al.. Low back pain. Lancet 2018; 392: 2547.", "ArticleIdList": ["30563633"]}, {"Citation": "Humzah MD, Soames RW. Human intervertebral disc: structure and function. Anat Rec 1988; 220: 337\u2013356.", "ArticleIdList": ["3289416"]}, {"Citation": "Johnson ZI, Schoepflin ZR, Choi H, et al.. Disc in flames: roles of TNF-\u03b1 and IL-1\u03b2 in intervertebral disc degeneration. Eur Cell Mate 2015; 30: 104\u2013117.", "ArticleIdList": ["PMC4751407", "26388614"]}, {"Citation": "Burke JG, Watson RWG, McCormack D, et al.. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002; 84: 196\u2013201.", "ArticleIdList": ["11924650"]}, {"Citation": "Buttermann GR. The effect of spinal steroid injections for degenerative disc disease. Spine J 2004; 4: 495\u2013505.", "ArticleIdList": ["15363419"]}, {"Citation": "Karppinen J, Korhonen T, Malmivaara A, et al.. Tumor necrosis factor-\u03b1 monoclonal antibody, infliximab, used to manage severe sciatica. Spine (Phila Pa 1976) 2003; 28: 750\u2013753.", "ArticleIdList": ["12698115"]}, {"Citation": "Sainoh T, Orita S, Miyagi M, et al.. Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. J Orthop Sci 2016; 21: 2\u20136.", "ArticleIdList": ["26755382"]}, {"Citation": "Kallewaard JW, Wintraecken VM, Geurts JW, et al.. A multicenter randomized controlled trial on the efficacy of intradiscal methylene blue injection for chronic discogenic low back pain: the IMBI study. Pain 2019; 160: 945\u2013953.", "ArticleIdList": ["30730862"]}, {"Citation": "Peng B, Zhang Y, Hou S, et al.. Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Eur Spine J 2007; 16: 33\u201338.", "ArticleIdList": ["PMC2198898", "16496191"]}, {"Citation": "Peng B, Pang X, Wu Y, et al.. A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Pain 2010; 149: 124\u2013129.", "ArticleIdList": ["20167430"]}, {"Citation": "Knezevic NN, Mandalia S, Raasch J, et al.. Treatment of chronic low back pain \u2013 new approaches on the horizon. J Pain Res 2017; 10: 1111\u20131123.", "ArticleIdList": ["PMC5436786", "28546769"]}, {"Citation": "Jenner JR, Buttle DJ, Dixon AK. Mechanism of action of intradiscal chymopapain in the treatment of sciatica: a clinical, biochemical, and radiological study. Ann Rheum Dis 1986; 45: 441\u2013449.", "ArticleIdList": ["PMC1001914", "3729572"]}, {"Citation": "Volpentesta G, De Rose M, Bosco D, et al.. Lumbar percutaneous intradiscal injection of radiopaque gelified ethanol (Discogel) in patients with low back and radicular pain. J Pain Relief 2014: 145."}, {"Citation": "Charneux L, Demoulin C, Vanderthomment M, et al.. [Platelet-rich plasma (PRP) and disc lesions: a review of the literature]. Neurochirurgie 2017; 63: 473\u2013477.", "ArticleIdList": ["29128087"]}, {"Citation": "Giurazza F, Guarnieri G, Murphy KJ, et al.. Intradiscal O2O3: Rationale, injection technique, short- and long-term outcomes for the treatment of low back pain due to disc herniation. Can Assoc Radiol J 2017; 68: 171\u2013177.", "ArticleIdList": ["28438284"]}, {"Citation": "Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100.", "ArticleIdList": ["PMC2707010", "19621070"]}, {"Citation": "Chiarotto A, Boers M, Deyo RA, et al.. Core outcome measurement instruments for clinical trials in nonspecific low back pain. Pain 2018; 159: 481\u2013495.", "ArticleIdList": ["PMC5828378", "29194127"]}, {"Citation": "World Health Organization. Quality assurance and safety of medicines team. (2002). Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. Geneva: World Health Organization, 2002."}, {"Citation": "Jadad AR, Moore RA, Carroll D, et al.. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1\u201312.", "ArticleIdList": ["8721797"]}, {"Citation": "\nHiggins JPT, Green S.\nCochrane Handbook for Systematic Reviews of Interventions Version\n5.1.0. The Cochrane Collaboration, www.handbook.cochrane.org (2011, accessed\n13 July 2018)."}, {"Citation": "Hartling L, Ospina M, Liang Y, et al.. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009; 339: b4012.", "ArticleIdList": ["PMC2764034", "19841007"]}, {"Citation": "Atkins D, Best D, Briss PA, et al.. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.", "ArticleIdList": ["PMC428525", "15205295"]}, {"Citation": "Higgins JP, Thompson SG, Deeks JJ, et al.. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557\u2013560.", "ArticleIdList": ["PMC192859", "12958120"]}, {"Citation": "Chou R, Hashimoto R, Friedly J, et al.. Pain management injection therapies for low back pain. Rockville, MD: Agency for Healthcare Research and Quality, 2015.", "ArticleIdList": ["25879124"]}, {"Citation": "van Tulder M, Furlan A, Bombardier C, et al.. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003; 28: 1290\u20131299.", "ArticleIdList": ["12811274"]}, {"Citation": "Cao P, Jiang L, Zhuang C, et al.. Intradiscal injection therapy for degenerative chronic discogenic low back pain with end plate Modic changes. Spine J 2011; 11: 100\u2013106.", "ArticleIdList": ["20850390"]}, {"Citation": "Nguyen C, Boutron I, Baron G, et al.. Intradiscal glucocorticoid injection for patients with chronic low back pain associated with active discopathy: a randomized trial. Ann Intern Med 2017; 166: 547\u2013556.", "ArticleIdList": ["28319997"]}, {"Citation": "Khot A, Bowditch M, Powell J, et al.. The use of intradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial. Spine 2004; 29: 833\u2013836; discussion 837.", "ArticleIdList": ["15082979"]}, {"Citation": "Tavares I, Thomas E, Cyteval C, et al.. Intradiscal glucocorticoids injection in chronic low back pain with active discopathy: a randomized controlled study. Ann Phys Rehabil Med. Epub ahead of print 27 August 2020. DOI: 10.1016/j.rehab.2020.05.003.", "ArticleIdList": ["10.1016/j.rehab.2020.05.003.", "32461125"]}, {"Citation": "Yu Y, Liu W, Song D, et al.. Diagnosis of discogenic low back pain in patients with probable symptoms but negative discography. Arch Orthop Trauma Surg 2012; 132: 627\u2013632.", "ArticleIdList": ["22228279"]}, {"Citation": "Sainoh T, Orita S, Miyagi M, et al.. Single intradiscal administration of the tumor necrosis factor-alpha inhibitor, etanercept, for patients with discogenic low back pain. Pain Med 2016; 17: 40\u201345.", "ArticleIdList": ["26243249"]}, {"Citation": "Cohen SP, Wenzell D, Hurley RW, et al.. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology 2007; 107: 99\u2013105.", "ArticleIdList": ["17585221"]}, {"Citation": "\nDePuy. A clinical trial to evaluate the safety,\ntolerability and preliminary effectiveness of single administration\nintradiscal rhGDF-5 for the treatment of early stage lumbar disc\ndegeneration\nhttps://www.clinicaltrials.gov/ct2/show/NCT01182337\n(accessed 13 July 2018)."}, {"Citation": "\nDePuy. A multicenter, randomized, double-blind,\nplacebo controlled, clinical trial to evaluate the safety, tolerability and\npreliminary effectiveness of 2 doses of intradiscal rhGDF-5 (Single\nAdministration) for the treatment of early stage lumbar disc\ndegeneration, https://www.clinicaltrials.gov/ct2/show/NCT01124006\n(accessed 13 July 2018)."}, {"Citation": "Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al.. Lumbar intradiskal Platelet-Rich Plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R 2016; 8: 1\u201310; quiz 10.", "ArticleIdList": ["26314234"]}, {"Citation": "Noriega DC, Ardura F, Hernandez-Ramajo R, et al.. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation 2017; 101: 1945\u20131951.", "ArticleIdList": ["27661661"]}, {"Citation": "Feldman J, Menkes CJ, Pallardy G, et al.. [Double-blind study of the treatment of disc lumbosciatica by chemonucleolysis]. Rev Rhum Mal Osteoartic 1986; 53: 147\u2013152.", "ArticleIdList": ["2939542"]}, {"Citation": "Kotilainen E, Muittari P, Kirvela O. Intradiscal glycerol or bupivacaine in the treatment of low back pain. Acta Neurochir (Wien) 1997; 139: 541\u2013545.", "ArticleIdList": ["9248588"]}, {"Citation": "Elawamy A, Kamel EZ, Hassanien M, et al.. Implication of two different doses of intradiscal ozone-oxygen injection upon the pain alleviation in patients with low back pain: a randomized, single-blind study. Pain Physician 2018; 21: E25\u2013E31.", "ArticleIdList": ["29357333"]}, {"Citation": "Niu T, Lv C, Yi G, et al.. Therapeutic effect of medical ozone on lumbar disc herniation. Med Sci Monit 2018; 24: 1962\u20131969.", "ArticleIdList": ["PMC5896688", "29611536"]}, {"Citation": "Younes M, Neffati F, Touzi M, et al.. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine 2007; 74: 472\u2013476.", "ArticleIdList": ["17919959"]}, {"Citation": "Horii M, Orita S, Nagata M, et al.. Direct application of the tumor necrosis factor-alpha inhibitor, etanercept, into a punctured intervertebral disc decreases calcitonin gene-related peptide expression in rat dorsal root ganglion neurons. Spine 2011; 36: E80\u2013E85.", "ArticleIdList": ["21057386"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "10"}, {"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "8", "Day": "5", "Hour": "6", "Minute": "26"}, {"Year": "2021", "Month": "8", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "7", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["34349845", "PMC8287365", "10.1177/1759720X211028001", "10.1177_1759720X211028001"]}}], "PubmedBookArticle": []}